Viewing Study NCT00972335


Ignite Creation Date: 2025-12-24 @ 10:36 PM
Ignite Modification Date: 2026-02-08 @ 10:31 AM
Study NCT ID: NCT00972335
Status: TERMINATED
Last Update Posted: 2021-11-10
First Post: 2009-09-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma
Sponsor: SCRI Development Innovations, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Intracranial Meningioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Avastin View
None RAD001 View
None Meningioma View
None Bevacizumab View
None Everolimus View
None Brain View